BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16291600)

  • 1. Evaluation of the efficacy and safety of etoricoxib in the treatment of hemophilic arthropathy.
    Tsoukas C; Eyster ME; Shingo S; Mukhopadhyay S; Giallella KM; Curtis SP; Reicin AS; Melian A
    Blood; 2006 Mar; 107(5):1785-90. PubMed ID: 16291600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
    Bickham K; Kivitz AJ; Mehta A; Frontera N; Shah S; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Aug; 17():331. PubMed ID: 27502582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability--a randomized, placebo-controlled, 3-month trial.
    Birbara CA; Puopolo AD; Munoz DR; Sheldon EA; Mangione A; Bohidar NR; Geba GP;
    J Pain; 2003 Aug; 4(6):307-15. PubMed ID: 14622687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Further assessment of the clinically effective dose range of etoricoxib: a randomized, double-blinded, placebo-controlled trial in rheumatoid arthritis.
    Greenwald M; Peloso PM; Mandel D; Soto O; Mehta A; Frontera N; Boice JA; Zhan XJ; Curtis SP
    Curr Med Res Opin; 2011 Oct; 27(10):2033-42. PubMed ID: 21905970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.
    van der Heijde D; Baraf HS; Ramos-Remus C; Calin A; Weaver AL; Schiff M; James M; Markind JE; Reicin AS; Melian A; Dougados M
    Arthritis Rheum; 2005 Apr; 52(4):1205-15. PubMed ID: 15818702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic etoricoxib is effective in preventing Yom Kippur headache: a placebo-controlled double-blind and randomized trial of prophylaxis for ritual fasting headache.
    Drescher MJ; Alpert EA; Zalut T; Torgovicky R; Wimpfheimer Z
    Headache; 2010 Sep; 50(8):1328-34. PubMed ID: 20039959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoricoxib in the treatment of osteoarthritis over 52-weeks: a double-blind, active-comparator controlled trial [NCT00242489].
    Curtis SP; Bockow B; Fisher C; Olaleye J; Compton A; Ko AT; Reicin AS
    BMC Musculoskelet Disord; 2005 Dec; 6():58. PubMed ID: 16321158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, clinical trial to assess the relative efficacy and tolerability of two doses of etoricoxib versus naproxen in patients with ankylosing spondylitis.
    Balazcs E; Sieper J; Bickham K; Mehta A; Frontera N; Stryszak P; Popmihajlov Z; Peloso PM
    BMC Musculoskelet Disord; 2016 Oct; 17(1):426. PubMed ID: 27737664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gastrointestinal safety of the COX-2 selective inhibitor etoricoxib assessed by both endoscopy and analysis of upper gastrointestinal events.
    Hunt RH; Harper S; Watson DJ; Yu C; Quan H; Lee M; Evans JK; Oxenius B
    Am J Gastroenterol; 2003 Aug; 98(8):1725-33. PubMed ID: 12907325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative use of etoricoxib reduces pain and opioid side-effects after total abdominal hysterectomy: a double-blind, randomized, placebo-controlled phase III study.
    Viscusi ER; Frenkl TL; Hartrick CT; Rawal N; Kehlet H; Papanicolaou D; Gammaitoni A; Ko AT; Morgan LM; Mehta A; Curtis SP; Peloso PM
    Curr Med Res Opin; 2012 Aug; 28(8):1323-35. PubMed ID: 22738802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of etoricoxib in patients undergoing total knee replacement surgery in a double-blind, randomized controlled trial.
    Rawal N; Viscusi E; Peloso PM; Minkowitz HS; Chen L; Shah S; Mehta A; Chitkara DK; Curtis SP; Papanicolaou DA
    BMC Musculoskelet Disord; 2013 Oct; 14():300. PubMed ID: 24156640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single dose oral etoricoxib for acute postoperative pain in adults.
    Clarke R; Derry S; Moore RA
    Cochrane Database Syst Rev; 2012 Apr; (4):CD004309. PubMed ID: 22513922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the dose range of etoricoxib in an acute pain setting using the postoperative dental pain model.
    Daniels SE; Bandy DP; Christensen SE; Boice J; Losada MC; Liu H; Mehta A; Peloso PM
    Clin J Pain; 2011 Jan; 27(1):1-8. PubMed ID: 21188849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy and safety of etoricoxib compared with naproxen in two, 138-week randomised studies of patients with osteoarthritis.
    Reginster JY; Malmstrom K; Mehta A; Bergman G; Ko AT; Curtis SP; Reicin AS
    Ann Rheum Dis; 2007 Jul; 66(7):945-51. PubMed ID: 17142385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic etoricoxib is effective in preventing "first of Ramadan" headache: a placebo-controlled double-blind and randomized trial of prophylactic etoricoxib for ritual fasting headache.
    Drescher MJ; Wimpfheimer Z; Abu Khalef S; Gammaitoni A; Shehadeh N; Torgovicky R
    Headache; 2012 Apr; 52(4):573-81. PubMed ID: 21848948
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273].
    Collantes E; Curtis SP; Lee KW; Casas N; McCarthy T; Melian A; Zhao PL; Rodgers DB; McCormick CL; Lee M; Lines CR; Gertz BJ;
    BMC Fam Pract; 2002 May; 3():10. PubMed ID: 12033987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of etoricoxib, a specific cyclooxygenase-2 inhibitor, in asthmatic patients with aspirin-exacerbated respiratory disease.
    El Miedany Y; Youssef S; Ahmed I; El Gaafary M
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):105-9. PubMed ID: 16892790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Etoricoxib in acute pain associated with dental surgery: a randomized, double-blind, placebo- and active comparator-controlled dose-ranging study.
    Malmstrom K; Sapre A; Couglin H; Agrawal NG; Mazenko RS; Fricke JR
    Clin Ther; 2004 May; 26(5):667-79. PubMed ID: 15220011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Results of a randomized, dose-ranging trial of etoricoxib in patients with osteoarthritis.
    Gottesdiener K; Schnitzer T; Fisher C; Bockow B; Markenson J; Ko A; DeTora L; Curtis S; Geissler L; Gertz BJ;
    Rheumatology (Oxford); 2002 Sep; 41(9):1052-61. PubMed ID: 12209041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis.
    Matsumoto AK; Melian A; Mandel DR; McIlwain HH; Borenstein D; Zhao PL; Lines CR; Gertz BJ; Curtis S;
    J Rheumatol; 2002 Aug; 29(8):1623-30. PubMed ID: 12180720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.